[1]Wang X, Lin YK, Lu ZL, et al. Circular RNA circ-MTO1 serves as a novel potential diagnostic and prognostic biomarker for gallbladder cancer [J]. Eur Rev Med Pharmacol Sci, 2020, 24: 8359-8366.doi:10.26355/eurrev_202008_22632. [2]周迪, 翁明哲, 全志伟. “意外胆囊癌”不规范诊断命名的纠正和预防策略[J]. 中华外科杂志,2020, 58:490-493 [3]Yamaguchi J, Kaneoka Y, Maeda A, et al. Benefit of extended radical surgery for incidental gallbladder carcinoma [J]. Surg Today, 2016, 46: 453-459.doi:10.1007/s00595-015-1198-z. [4]Zhang HP, Bai M, Gu JY, et al. Value of contrast-enhanced ultrasound in the differential diagnosis of gallbladder lesion [J]. World J Gastroenterol, 2018, 24: 744-751.doi:10.3748/wjg.v24.i6.744. [5]Kong WT, Shen HY, Qiu YD, et al. Application of contrast enhanced ultrasound in gallbladder lesion: is it helpful to improve the diagnostic capabilities? [J]. Med Ultrason, 2018, 20: 420-426.doi:10.11152/mu-1626. [6]Chen LD, Huang Y, Xie XH, et al. Diagnostic nomogram for gallbladder wall thickening mimicking malignancy: using contrast-enhanced ultrasonography or multi-detector computed tomography? [J]. Abdom Radiol (NY), 2017, 42: 2436-2446.doi:10.1007/s00261-017-1162-z. [7]Miwa H, Numata K, Sugimori K, et al. Differential diagnosis of gallbladder polypoid lesions using contrast-enhanced ultrasound [J]. Abdom Radiol (NY), 2019, 44: 1367-1378.doi:10.1007/s00261-018-1833-4. [8]Serra C, Felicani C, Mazzotta E, et al. CEUS in the differential diagnosis between biliary sludge, benign lesions and malignant lesions [J]. J Ultrasound, 2018, 21: 119-126.doi:10.1007/s40477-018-0286-5. [9]Jang SI, Kim YJ, Kim EJ, et al. Diagnostic performance of endoscopic ultrasound-artificial intelligence using deep learning analysis of gallbladder polypoid lesions [J]. J Gastroenterol Hepatol, 2021, 36: 3548-3555.doi:10.1111/jgh.15673. [10]Sugimoto M, Irie H, Takasumi M, et al. A simple method for diagnosing gallbladder malignant tumors with subserosa invasion by endoscopic ultrasonography [J]. BMC Cancer, 2021, 21: 288.doi:10.1186/s12885-021-08017-x. [11]Kang Y, Chae YS, Kim CH, et al. Hyalinizing cholecystitis and associated carcinoma: a case report [J]. J Pathol Transl Med, 2018, 52: 64-66.doi:10.4132/jptm.2016.11.04. [12]Yuan HX, Cao JY, Kong WT, et al. Contrast-enhanced ultrasound in diagnosis of gallbladder adenoma [J]. Hepatobiliary Pancreat Dis Int, 2015, 14: 201-207.doi:10.1016/s1499-3872(15)60351-4. [13]Kim SY, Cho JH, Kim EJ, et al. The efficacy of real-time colour Doppler flow imaging on endoscopic ultrasono-graphy for differential diagnosis between neoplastic and non-neoplastic gallbladder polyps [J]. Eur Radiol, 2018, 28: 1994-2002.doi:10.1007/s00330-017-5175-3. [14]Han H, Han J. Value of multislice spiral CT in differen-tial diagnosis of thick-wall gallbladder carcinoma and chronic cholecystitis [J]. Contrast Media Mol Imaging, 2022, 2022: 5459779.doi:10.1155/2022/5459779. [15]Corwin MT, Khera SS, Loehfelm TW, et al. Incidentally detected focal fundal gallbladder wall thickening at contrast-enhanced computed tomography: prevalence and computed tomography features of malignancy [J]. J Comput Assist Tomogr, 2019, 43: 149-154.doi:10.1097/RCT.0000000000000802. [16]Cha SY, Kim YK, Min JH, et al. Usefulness of noncontrast MRI in differentiation between gallbladder carcinoma and benign conditions manifesting as focal mild wall thickening [J]. Clin Imaging, 2019, 54: 63-70.doi:10.1016/j.clinimag.2018.12.001. [17]Chu R, Bi W, Tian B, et al. The role of ultrasonography in the diagnosis of gallbladder cancer [J]. Ann Ital Chir, 2021, 92: 372-376. [18]Liu XF, Zhou LY, Wei ZH, et al. The diagnostic role of circulating inflammation-based biomarker in gallbladder carcinoma [J]. Biomark Med, 2018, 12: 1095-1103.doi:10.2217/bmm-2018-0049. [19]Vinocha A, Grover RK, Deepak R. Clinical signifi-cance of interleukin-6 in diagnosis of lung, oral, esophageal, and gall bladder carcinomas [J]. J Cancer Res Ther, 2018, 14: S758-S760.doi:10.4103/0973-1482.183217. [20]Wan Y, Zhang J, Chen M, et al. Elevated serum triglyceride levels may be a key independent predicting factor for gallbladder cancer risk in gallbladder stone disease patients: a case-control study [J]. BMC Endocr Disord, 2022, 22: 270.doi:10.1186/s12902-022-01189-y. [21]Priya R, Jain V, Akhtar J, et al. Plasma-derived candidate biomarkers for detection of gallbladder carcino-ma [J]. Sci Rep, 2021, 11: 23554.doi:10.1038/s41598-021-02923-7. [22]Bind MK, Mishra RR, Kumar V, et al. Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder [J]. Indian J Pathol Microbiol, 2021, 64: 65-68.doi:10.4103/IJPM.IJPM_494_19. [23]Ozer N, Sozutek A, Sahin A, et al. The role of Ca 19-9, Ca 72-4, cea and cholesterol levels in predicting malignancy in gallbladder polyps [J]. J Coll Physicians Surg Pak, 2021, 31: 1422-1427.doi:10.29271/jcpsp.2021.12.1422. [24]Yang G, Lu Z, Meng F, et al. Circulating miR-141 as a potential biomarker for diagnosis, prognosis and thera-peutic targets in gallbladder cancer [J]. Sci Rep, 2022, 12: 10072.doi:10.1038/s41598-022-13430-8. |